<?xml version="1.0" encoding="UTF-8"?>
<list list-type="bullet" id="list1-2049936120947517">
 <list-item>
  <p>Given the promising early 
   <italic>in vitro</italic> results and therapeutic dilemma, the compassionate use of CQ/HCQ in COVID-19 can be an option.
  </p>
 </list-item>
 <list-item>
  <p>However, there is no convincing clinical evidence to support the use of CQ and HCQ, either alone or in combination with azithromycin, in COVID-19.</p>
 </list-item>
 <list-item>
  <p>Misuse of CQ/HCQ or use beyond the prescription can result in serious health problems, including cardiac toxicity and even death.</p>
 </list-item>
 <list-item>
  <p>It is recommended to avoid high dose CQ/HCQ and exercise extreme caution while using CQ/HCQ even in hospitalised patients.</p>
 </list-item>
 <list-item>
  <p>Clinicians and researchers should regularly update and adhere to the available credible evidence and findings of the ongoing clinical trials.</p>
 </list-item>
</list>
